|
Molecular Targets Development
Program
|
|
|
|
The MTDP
- provides leadership for the translation of basic
science advances into drug leads, bioprobes and reagents for molecular target
evaluation. We exploit chemical and biodiversity repositories, including the
NCI Natural Products Repository, for molecularly-targeted lead discovery; and
- facilitates the discovery of natural products and
synthetic compounds that may serve as bioprobes for chemical genetics,
proteomics, target validation and potential lead compounds for clinical
development. Compounds of interest include not only classical,
drug-like organic small molecules, but also peptides, proteins, and
other bioactive chemical classes.
|
|
|
|
© 2000-2005 Center for Cancer Research
at the National Cancer Institute. questions, comments, and suggestions to
webmaster Last modified November 7,
2005 |
|
Home |
Mission | Organization | News |
|